Go back to Database: Netherlands Cancer Registry (NKR) (The Netherlands) page.
Source: Click here to learn more.
There are different types of variables available according to type of tumor and date range. But here we present a general overview of the variables. For more detailed information about the variables available for each type of tumor, visit the data source.
Patient Records
| Date of birth
|
| Age at diagnosis
|
| Sex
|
| Country of birth
|
| Date of death
|
| Vital status with date
|
| Patient number in the institution
|
| Menopausal status at diagnosis
|
| Postcode figures
|
Tumor Data
| Diagnosis date
|
| Basis for diagnosis
|
| Topography (incl. sublocalization/lateralization)
|
| Morphology (incl. behavior/degree of differentiation)
|
| Topography metastasis (incl. sublocalization)
|
| Clinical TNM stage
|
| Pathological TNM stage
|
| Multifocality tumor
|
| Pathological size of the tumor (mm)
|
| Estrogen receptor status
|
| Estrogen receptor value
|
| Progesterone receptor status
|
| Value of progesterone receptor
|
| HER2 status
|
| Technique used for HER2 determination
|
| Number of regional lymph nodes examined
|
| Number of positive regional lymph nodes
|
| Presence of DCIS component next to invasive tumor
|
| BI-RADS classification
|
| Tumor palpability
|
| Breast print rash
|
| Result of oncotype DX
|
Treatment Details
| Surgery
|
| Date of surgery
|
| Surgery discharge date
|
| Tumor is an incidental finding during surgery for another indication
|
| Hospital surgery
|
| Direct reconstruction
|
| Date of immediate reconstruction
|
| Direct reconstruction technique
|
| Hospital direct reconstruction
|
| Axillary dissection performed
|
| Date of axillary lymph node dissection
|
| Hospital axillary dissection
|
| Basic axillary dissection performed
|
| Date of basal axillary lymph node dissection
|
| Hospital of basal axillary dissection
|
| Radiotherapy
|
| Start/stop date of radiotherapy
|
| Type of external radiotherapy
|
| Hospital radiotherapy
|
| Systemic chemotherapy
|
| Start/stop date of systemic chemotherapy
|
| Hospital systemic chemotherapy
|
| Systemic hormonal therapy
|
| Start date of systemic hormonal therapy
|
| Hospital systemic hormonal therapy
|
| Systemic target therapy
|
| Start-stop date of systemic target therapy
|
| Hospital systemic target therapy
|
| Active surveillance
|
| Radicality DCIS component surgery
|
| Radicality invasive component surgery
|
| No radiotherapy after breast-conserving treatment
|
| Reason for no radiotherapy after breast-conserving treatment
|
| Complication during/after surgery
|
| Complication during/after systemic chemotherapy
|
Follow up Data
| Recurrences within 5 years of diagnosis
|
| Follow-up local recurrence
|
| Date of follow-up local recurrence
|
| Localization of follow-up local recurrence
|
| Basis for diagnosis of follow-up local recurrence
|
| Pathological tumor size (mm) follow-up local recurrence
|
| Follow-up regional recurrence
|
| Date of follow-up for regional recurrence
|
| Localization of follow-up regional recurrence
|
| Basis for diagnosis of follow-up regional recurrence
|
| Number of regional lymph nodes examined for follow-up regional recurrence
|
| Number of positive lymph nodes follow-up regionally
|
| Follow-up metastasis
|
| Date of follow-up metastasis
|
| Basis for diagnosis follow-up metastasis
|
| Topography (incl. sublocalization/lateralization) follow-up metastasis
|
| Number of follow-up metastases
|
| Treatment follow-up
|
| Date of last contact follow-up
|
| Relapses within 10 years of diagnosis
|
| Follow-up local recurrence
|
| Date of follow-up local recurrence
|
| Follow-up regional recurrence
|
| Date of follow-up for regional recurrence
|
| Follow-up metastasis
|
| Date of follow-up metastasis
|
| Treatment follow-up
|
| Relapses due to project
|
| Follow-up local recurrence
|
| Localization of local recurrence
|
| Basis for diagnosis of local recurrence
|
| Date of follow-up local recurrence
|
| Pathological tumor size (mm) follow-up local recurrence
|
| Follow-up regional recurrence
|
| Localization of regional recurrence
|
| Basis for diagnosis of regional recurrence
|
| Date of follow-up for regional recurrence
|
| Number of regional lymph nodes examined for follow-up regional recurrence
|
| Number of positive lymph nodes follow-up regional recurrence
|
| Follow-up metastasis
|
| Localization of metastasis
|
| Basis for diagnosis of metastasis
|
| Date of follow-up metastasis
|
| Number of follow-up metastases
|
| ER, PR, Her2 recurrence or metastasis
|
| Treatment follow-up
|
Risk Factors
| Comorbidity
|
| History of breast surgery
|
| Smoking status
|
| Pregnancy at diagnosis
|
| Performance status
|
| Weight
|
| Length
|
| Incidence year of previous/later malignancies
|
| Tumor type previous/later malignancies
|
Process Data
| Tumor detected after referral for population screening
|
| Reason for diagnosis
|
| Gene mutation research conducted
|
| Date of gene mutation research
|
| Hospital gene mutation research
|
| MRI performed
|
| MRI date
|
| Hospital MRI
|
| Ultrasound-guided puncture and/or biopsy performed in the armpit
|
| Date of ultrasound-guided puncture and/or biopsy in the armpit
|
| Result of ultrasound-guided puncture and/or biopsy in armpit
|
| Hospital ultrasound-guided puncture and/or biopsy in the armpit
|
| Post-therapeutic MDO performed
|
| Date post-therapeutic MDO
|
| Hospital post-therapeutic MDO
|
| Pretherapeutic MDO performed
|
| Date of pre-therapeutic MDO
|
| Hospital pretherapeutic MDO
|
| Sentinel lymph node procedure performed
|
| Date of sentinel procedure
|
| Result of sentinel procedure
|
| Hospital sentinel procedure
|
| Tumor localization procedure
|
| MARI procedure performed
|
| Date of MARI procedure
|
| Result of MARI procedure
|
| Hospital MARI procedure
|
| Date of first consultation with plastic surgeon for ablation
|
| Date of first consultation with radiotherapist for pre-surgical therapy
|
| Hospital of first contact regarding malignancy
|
| Date of first consultation in hospital
|
| Date of first consultation with practitioner at second hospital
|
| Participation in clinical scientific research
|
| Operation with plastic surgeon
|
